Linked Life Data

16425107

Source:http://linkedlifedata.com/resource/pubmed/id/16425107

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
21-22
pubmed:dateCreated
2006-1-20
pubmed:abstractText
Despite ongoing controversy, homeopathy has become increasingly accepted as a "medical reality" by patients and doctors alike. This process has been accompanied by an increased quality of manufacturing, education, research, and regulation of homeopathy. This paper argues that European regulation may now have gone too far by indiscriminately prescribing that homeopathic medicines should be used in a potency of D4 and higher. Low potencies and tinctures are an important and integral part of the homeopathic heritage. The regulatory environment therefore appears to be hampering one of its own principal aims: the availability of safe and high-quality homeopathic products that practitioners, patients and consumers want and need.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0043-5341
pubmed:author
pubmed:issnType
Print
pubmed:volume
155
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
479-81
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed:year
2005
pubmed:articleTitle
To which extent should potency choice in homeopathy be "regulated": has European legislation gone too far?
pubmed:affiliation
International Institute for Integrated Medicine, Kingston, Surrey, United Kingdom. vanhaselen@compuserve.com
pubmed:publicationType
Journal Article